We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -1.79% | 13.75 | 13.50 | 14.00 | 14.00 | 13.75 | 14.00 | 492,464 | 12:20:32 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 1.04M | -21.69M | -0.0832 | -1.65 | 35.83M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/4/2024 20:18 | Krypton And anyone also knows there is a mechanism to reduce the nominal value if they can’t get backers at 10p. The good news is the company value is not crazy. The bad is the likely cash level needed v the share price. If you have 260m shares in issue (MC £36m) at 14p and need £20m at 10p, that would mean 460m shares, say 11p open making the MC £50m, yet the burn is over 1m per month. So the claims of below 10p are not fantasy, countless AIM companies have seen share prices destroyed and diluted to oblivion in this market. Angle fortunately have something of apparent value, but years of lack of uptake will be used as leverage against them to push them lower. It’s a bad bargaining position start point. To be concluded in the coming weeks no doubt. Until it’s done everyday (without major deal news) is a gloomy day. Let’s hope results don’t have any, lower than expected, pushed into 2025 etc as the vultures will have even more discount ammo. | ohwhatfun | |
30/4/2024 17:49 | NEW RESEARCH in Sheffield to investigate protein that fuels BREAST cancer. Breast Cancer Now has awarded £250k to Dr Elena Rainero at the UNIVERSITY of SHEFFIELD, to study how BREAST cancer cells use alternative food sources to grow and spread, and the role a protein called a2b1 integrin plays in this process. This research COULD uncover a cancer-specific process which may lead to the development of treatments that come with fewer side effects for patients, as healthy cells won't be affected.Https://onc | 5oletrader | |
30/4/2024 16:48 | Anyone heard of Robert Zeillinger before or any Angle involvement? He appears to have a medical diagnostics company and been involved in funding the above research… | gspanner | |
30/4/2024 16:35 | So worth looking at Mr K’s link… ‘Early access’ via the internet to an EJC article where 473 samples were analysed with parsortix to analyse whether an assay of ESR1 and ERCC1 is predictive Of response in platinum resistant ovarian cancer. It was! It’s a helpful example of how parsotix can become mainstream potentially over a number of tumour sites potentially tailoring therapy for millions of patients… And I would presume the analysis of the 473 patients will hit the bottom line these results… £473k ? (At least) | gspanner | |
30/4/2024 13:24 | Many thanks for the link Mr. K, 'hope all's going well with your treatment. | danwaits | |
30/4/2024 12:15 | You may as well ask your cat. In fact you'd get a more intelligent reply from it. Don't engage. Better to discuss more relevant subjects. | boris cobaka | |
30/4/2024 11:08 | If this is such a certainty with regards to a placing, ie, first 14p, then 10p and now 7p.....Why were there no shorts opened against this company?....explain? | htrocka2 | |
30/4/2024 10:08 | Credit to KOR on Telegram group.https://online | mrkeysersoze | |
30/4/2024 09:48 | Why do you keep posting negative comments....are you trying to make money shorting or hope to buy lower. Yes you are. Foolish.No one cares of your opinion. Worthless. | muffster | |
30/4/2024 08:33 | Clearly cr@p financial results expected and more 'jam' tommorrow from Newland with a subtle hint that 'strategic' options include a cash raise but at what price to 'mug' sorry entice investors I'm going 8p! | bones699 | |
30/4/2024 01:12 | Chunky delayed buy from Friday put thru first thing. Almost 40k. Results coming up. | boris cobaka | |
29/4/2024 21:51 | Angle is getting noticed. This is their LinkedIn page. 12,685 Followers. | outsizeclothes.com | |
29/4/2024 21:20 | Timmmmmberrrrrr Placing anyone ? 7p? | havinthelasttoast | |
29/4/2024 13:57 | Remember the Spanish Inquisition according to Monty Python.......... | liberatingsteptoe | |
29/4/2024 12:52 | Yep I sold half at 16p and the rest this morning for circa 10% less. Definitely still interested as I like the company and expect to buy back much lower after what I expect to be underwhelming results and a raise. | adw198 | |
29/4/2024 12:49 | For someone who apparently dumped all their shares this morning you seem quite invested in this board LMAO | zeus19 | |
29/4/2024 12:10 | If they thought the deals and milestone payments (whatever that means) were likely why wouldn’t they be included in the revenue projection for this year? | adw198 | |
29/4/2024 12:07 | And it’s absolutely fine for you to think they won’t need to raise funds because the magic money tree will gift us about 5 times more revenue than we’ve ever achieved. I just think they’ll go to market. One of us will be right. | adw198 | |
29/4/2024 11:45 | Angle did not say a placing would be needed They said there will be a funding short fall to make up They are looking to fill that with sales, deals and milestone payments etc They have until early 2025 to do the above Change the placing theory record because it's getting as boring as you LOLsss | kryptonsnake | |
29/4/2024 11:40 | Did the company tell you what happens after the 6 months? What about other deals and sales? You know nothing LOLsss | kryptonsnake | |
29/4/2024 11:39 | The 'shareholder/institu What if some company, like AZ or Essai, took, let's say, a 10%-20% stake in Angle for the necessary money? What if they managed to get away a high interest bond? | outsizeclothes.com | |
29/4/2024 11:25 | Nothing material £££ will come from the AZ deal prior to the cash running out. That’s my view - yours appears to be that we won’t need funding despite the company themselves saying they will. | adw198 | |
29/4/2024 11:20 | Bermudashorts - Post Rec your 24086. | gooosed |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions